fullscreen

eFinder

eFinder

Daily Briefing
FDA approves ‘life-altering’ pancreatic cancer drug that nearly doubles life expectancy

FDA approves ‘life-altering’ pancreatic cancer drug that nearly doubles life expectancy See more of our coverage in your search results. The US Food and Drug Administration announced Wednesday it has approved a groundbreaking treatment option for pancreatic cancer. Manufactured by Revolution Medicines, daraxonrasib made headlines earlier this year…

Story intelligence

0 claims checked
0Topics
0%Risk score
4 min readRead time
141846Articles analyzed
10Techniques tracked
15Sources monitored
LiveUpdated feed